Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,166 | -21,672 | -10,643 | -27,940 | -21,598 |
| Depreciation Amortization | 1,084 | 737 | 383 | 681 | 359 |
| Income taxes - deferred | -61 | -63 | N/A | N/A | 0 |
| Accounts receivable | 0 | -39 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 4,133 | -352 | -1,955 | -491 | -1,276 |
| Other Working Capital | 29,140 | -12,601 | -7,202 | 51,896 | 56,512 |
| Other Operating Activity | 351 | 3,337 | 3,446 | 5,938 | 5,436 |
| Operating Cash Flow | $-519 | $-30,653 | $-15,971 | $30,084 | $39,433 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -48,126 | 14,389 | -6,507 | -72,017 | 24,344 |
| PPE Investments | -69 | -69 | -39 | -802 | -314 |
| Investing Cash Flow | $-48,195 | $14,320 | $-6,546 | $-72,819 | $24,030 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,000 | 5,000 |
| Debt Repayment | -1,200 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 91,091 | 211 | 202 | 56,381 | 56,392 |
| Financing Cash Flow | $89,891 | $211 | $202 | $61,381 | $61,392 |
| Exchange Rate Effect | -37 | -24 | -15 | 58 | -35 |
| Beginning Cash Position | 35,213 | 35,213 | 35,213 | 16,509 | 16,509 |
| End Cash Position | 76,353 | 19,067 | 12,883 | 35,213 | 141,329 |
| Net Cash Flow | $41,140 | $-16,146 | $-22,330 | $18,704 | $124,820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -519 | -30,653 | -15,971 | 30,084 | 39,433 |
| Capital Expenditure | -69 | -69 | -39 | -802 | -314 |
| Free Cash Flow | -588 | -30,722 | -16,010 | 29,282 | 39,119 |